Skip to main content

Arterial and Venous Thrombotic Events in Patients with COVID-19 in Inpatient and Ambulatory Settings: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Health Outcome(s)
arterial thromboembolism
venous thromboembolism
Description

In this report, we identified individuals with COVID‐19 in the ambulatory and inpatient settings and examined inpatient arterial thrombotic events and inpatient venous thrombotic events among those individuals, as well as all‐cause mortality following an inpatient thrombotic event. This analysis was conducted as a follow‐up to the study described here.

The study period includes data from April 1, 2020 to May 4, 2022. We distributed this request to six Sentinel Data Partners on January 10, 2023. 

All of the code lists for this work have been published previously and can be found in this manuscript. 

Deliverables (1)
Sentinel Modular Program Report: Arterial and Venous Thrombotic Events in Patients with COVID-19 in Inpatient and Ambulatory Settings: A Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
April 1, 2020 – May 4, 2022
Analysis Type
Descriptive
Population / Cohort
Individuals 18 years of age and older
Data Sources
Sentinel Distributed Database (SDD)